FACTOR VIIA INHIBITORS

摘要

The present invention provides novel compounds of Formula (I): its prodrug forms, or pharmaceutically acceptable salts thereof. The compounds of this invention are inhibitors of Factor VIIa (fVIIa), and have utility as anticoagulants for the treatment or prevention of thromboembolic disorders in mammals.